In-vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp
about
Emerging drugs and vaccines for candidemiaPharmacokinetics and pharmacodynamics of antifungals in children: clinical implicationsIn vitro antifungal activities of the new triazole UR-9825 against clinically important filamentous fungiIn vitro activities of four novel triazoles against Scedosporium sppInteraction of gelatin with polyenes modulates antifungal activity and biocompatibility of electrospun fiber matsNew therapeutic options for onychomycosis.In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation.New and investigational triazole agents for the treatment of invasive fungal infections.Efficacy of albaconazole against Candida albicans in a vaginitis model.New generation azole antifungals in clinical investigation.New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.Antifungals to treat Candida albicans.Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations.Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases.Systemic Antifungal Agents: Current Status and Projected Future Developments.In vitro antiproliferative effects and mechanism of action of the new triazole derivative UR-9825 against the protozoan parasite Trypanosoma (Schizotrypanum) cruziIn vitro activities of 10 antifungal drugs against 508 dermatophyte strainsEfficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits.A randomized, double-blind, multiple-dose, placebo-controlled, dose escalation study with a 3-cohort parallel group design to investigate the tolerability and pharmacokinetics of albaconazole in healthy subjects.In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans.Newer antifungal agents.Synthesis and Biological Activity of Sterol 14α-Demethylase and Sterol C24-Methyltransferase Inhibitors
P2860
Q26828993-A383050F-46D2-495E-B2B7-D38E19710317Q27025299-619C1179-EE13-4622-BB71-308533A57EAEQ28345970-D88836BB-9C25-48E6-8105-75B816C995E4Q28366842-B3769024-4BEB-464E-99EE-D16857ABE706Q33706569-680B1A44-3157-488F-99AB-932A0B4B6C90Q34245375-FCDE5946-AFAD-46D2-8E9B-AA924AE8B298Q35103898-1490160E-E168-4901-A72B-A898893FE13EQ36491819-6F9173DF-09A6-4612-830B-D76E024BCF50Q36587695-050D5CD6-9609-4747-A830-2F6D156C3965Q37364295-4F415226-EA4A-4981-9F4B-6CD727706A0DQ37392798-25279E09-F5B2-40A5-A392-40A0DA3A3CF9Q37579222-E9EE283D-6BBE-43E7-B213-258B801AF0EEQ37608276-F19251A7-DAD2-4252-9672-8926890CAFEFQ37763928-EF73A66F-F7F3-4639-B1BC-2B007DA8C938Q37918556-1B5CAE2E-C9F3-411E-8BE5-A0D7CCDE7E7DQ38285488-54C9466A-80B0-44C0-933B-3C856827BBDEQ38796140-258C5C89-7524-40EE-98FD-2735C474682EQ39474980-EED5FC3C-B432-47E0-BE7D-659EAA5ED5BFQ39478246-9B1CA8E6-3179-4D54-B18E-64D47A1BC0E3Q39755529-0C539424-7EF2-4D2B-B8DD-DE716E92F7E2Q39810673-64DCAD5E-3ED5-4EDE-A4A7-770D28936FE6Q40469499-ED523B6A-FF4B-4B04-847E-834D43A4566DQ44855715-6A1BAC4C-3155-4515-B573-DFA1A0791249Q58842234-1B3210F4-6916-471B-AB23-350806BE7CC3
P2860
In-vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
In-vitro comparative activity ...... inical isolates of Candida spp
@ast
In-vitro comparative activity ...... inical isolates of Candida spp
@en
In-vitro comparative activity ...... inical isolates of Candida spp
@nl
type
label
In-vitro comparative activity ...... inical isolates of Candida spp
@ast
In-vitro comparative activity ...... inical isolates of Candida spp
@en
In-vitro comparative activity ...... inical isolates of Candida spp
@nl
prefLabel
In-vitro comparative activity ...... inical isolates of Candida spp
@ast
In-vitro comparative activity ...... inical isolates of Candida spp
@en
In-vitro comparative activity ...... inical isolates of Candida spp
@nl
P2093
P356
P1476
In-vitro comparative activity ...... inical isolates of Candida spp
@en
P2093
J L Rodríguez-Tudela
M Cuenca-Estrella
P356
10.1093/JAC/44.2.283
P407
P577
1999-08-01T00:00:00Z